Cranial scans were acquired in the primary position and in eight additional directions of gaze with eyes open and closed to demonstrate the mobility of the eyeball and the implant within the orbital cavity. Three-dimensional images were constructed to visualise the path of the implant from the retro-auricular space around the lateral orbital rim through the orbit and within the subretinal space up to the device's final para-foveal position. Images were obtainable in high quality, resulting in threedimensional models illustrating all parts of the implant including the micro-photodiode array at the tip in the subretinal space. The implant followed eye movements in all directions of gaze; eye movements were only minimally restricted as described in previous publications. Since all, except intra-ocular, parts of the implant evade direct examination, CT can be useful to assess the technical integrity and the biocompatibility and biostability of retinal implants.
INTRODUCTION
Subretinal implants are designed to restore visual function in diseases such as retinitis pigmentosa (RP) by replacing degenerated photoreceptors with microphotodiode arrays (MPDAs). 1e3 Since it has been shown that more energy is necessary than is available through microphotodiodes, 4 active subretinal implants with external connections have been constructed. 5 6 In this first clinical trial, transcutaneous access in the retro-auricular space provided important advantages: first, it allowed direct evaluation of electrode parameters such as impedance and charge transfer; and second, it provided maximum security and stability for the stimulation and driving circuits of the subretinal device. Future implants, however, will be fully implantable with wireless transmission of signals and energy.
After implantation, ophthalmological examination is limited to external aspects and to the ocular fundus, where the implant can be directly seen up to the point of trans-choroidal passage. However, the subdermal cable, the connection of the cable to the polyimide foil in the temporal fossa, and the passage of the foil around the lateral orbital rim through the orbit to the trans-choroidal passage all evade direct examination. Some groups applying epiretinal prostheses use similar extra-ocular routes, 7 8 while other groups prefer an all-intraocular approach. 9 In order to visualise an implant with extra-ocular parts in vivo, to evaluate it under strong eye movements and to examine the tissue surrounding it, we performed this exploratory study using highresolution CT.
Patients, material and methods
Two patients were included: both were male and suffered from end-stage RP with light perception.
Patient 1 (P1; 44 years old) was implanted in October 2005 in his right eye. Although the study period and insurance cover was granted for 4 weeks by the local ethics committee the patient refused explantation and he still carries the implant. The device's extra-corporeal parts in the retro-auricular area were removed and the skin closed after 12 months.
P2 (42 years old) was implanted in October 2007. Because of the onset of implant failure the extraocular parts were removed after 3 months (the study period was approved for 4 months at this point) and the intra-ocular parts 10 months postoperatively on the patient's decision.
The implant consisted of four connected parts (details are given in figure 1 ). The subretinally placed tip comprised two different entities: an MPDA with 1500 microphotodiodes for lightdriven stimulation and a 434 electrode array for direct electrical stimulation.
A SOMATOM Definition CT scanner (Siemens AG, Forchheim, Germany) was used. Collimation was 0.5 mm at 120 kV and 100 mA.
Digital Imaging and Communications in Medicine (DICOM) images of P1 were segmented using Amira (Visage Imaging GmbH, Berlin, Germany), exported as virtual reality modelling language (VRML) data and rendered in Maxon Cinema 4D (Maxon Computer GmbH, Friedrichsdorf, Germany). Images of P2 were segmented and rendered by the CT scanner's Leonardo workstation software (Siemens AG, Erlangen, Germany) to generate three-dimensional (3D) images. Final images and colours were obtained using Photoshop (Adobe Systems Inc., San Jose, California, USA).
Scans were taken in primary position (patient looking straight) with eyes open and eyes closed, and in eight cardinal directions of gaze: up, down, left, right, upper right, upper left, lower right, lower left.
RESULTS
CT scans were obtained in high quality with only minor adjustments to regular examination parameters for thin slice orbital examinations. Virtually all parts of the implant were clearly visible: the subretinal part with the 434 array and the thicker portion resembling the MPDA, the golden connection lanes on the polyimide foil in the subretinal < A Supplementary video is available online only. To view these files please visit the journal online (http://bjo.bmj. com).
space following the curvature of the posterior eyeball, its bend at the choroidal/scleral passage, the fixation pads for episcleral suturing, the foil's path through the orbital cavity and around the lateral orbital rim, the connection pad to the silicone cable in the temporal fossa, the silicone cable's way to the retro-auricular space, and the metal fixation clamp on the skull. Figure 2 shows four transversal sections of P1 with moderate soft tissue reaction to the orbital parts of the implant near the lateral orbital rim; all other structures within the orbital cavity, including sclera, optic nerve and eye muscles, seem unaffected. Figure 3 shows the steps to segment an original two-dimensional image to obtain a 3D image as shown in figures 4e6. Figure 4 shows 3D reconstructions for P1 from different angles along a transversal plane around the implant. In 3D reconstructions relative dimensions of various implant parts were evaluated to assess whether such measurements would yield meaningful results. The MPDA measured exactly 3 3 3 mm and was taken as reference in its largest presentation in CT images. The silicone cable measured 3.19 mm (3 mm in reality; averages of various measurements), the connection pad 9.6 mm (12 mm in reality; however, this structure was curved in the patient and was not measurable in full extension), the wider polyimide foil at the orbital rim 2.7 mm (2.5 mm in reality), the subretinal polyimide foil 1.5 mm (1.5 mm in reality). (1) a subretinal part (polyimide foil; 20-mm thick, 1.5e2.5 mm wide, about 22 mm long) with two entities at its tip: a 434 electrode array and a microphotodiode array with 1 500 photodiodes lying para-foveally; (2) an orbital part of the polyimide foil with fixation pads after choroidal and scleral perforation; at about 62 mm from the implant's tip a silicone pad is attached to the polyimide foil for suture fixation to the lateral orbital rim which connects via a connection pad to (3) a subdermal silicone cable (diameter 3 mm) containing 22 spiralled gold flexes; after clamp fixation it perforates the retro-auricular skin; (4) an extra-corporeal part of the silicone cable with a plug to an external generator for control signals and energy delivery. (B) A clamp was built from surgical steel for fixation of the implant on the scull bone in the retro-auricular region. The clamp consisted of a base plate, which was screwed into the scull bone, and a cover plate with a recess to jam the silicone cable onto the base plate (scale is in mm). Figure 6 shows four views of P1 at three different directions of gaze: straight, and upper right and lower left, causing maximum deflections in the orbit. Eye movements were minimally restricted in photographic gaze analysis, but were not described as disturbing by the patients. 5 A Supplementary video shows self-manoeuvrable 3D-animation that can be viewed using Quicktime (Apple Inc., Cupertino, California, USA; http://www.apple.com/quicktime/).
DISCUSSION
CT has been shown to be feasible in two patients with subretinal implants yielding strikingly illustrative pictures. CT is costeffective and can provide greater detail than any other technique including ultrasound sonography, which also has bad penetration depth in bone, and MRI, which is not recommended for this type of implant with cable wiring due to possible damage to the implants and surrounding tissue by high-frequency electromagnetic fields. Radiation exposure from CT scans, especially if Three-dimensional (3D) reconstructions of CT scans from patient 1. The scans were taken 21 months after implantation; the external parts of the implant and the metal clamp had been removed 12 months after implantation when granulation tissue had occurred at the skin perforation site and the implant was not used any more due to regulation by the ethics committee. All parts of the implant are clearly visible: (1) the subretinal tip with a microphotodiode array (MPDA) and the direct stimulation electrodes (coloured blue; colours do not represent differences in Hounsfield units, but rather were applied later to a raw 3D image allow better visualisation); (2) the fixation pads for episcleral fixation of the polyimide foil (red); (3) the orbital part of the polyimide foil; (4) the connection of the foil to the silicone cable in the temporal fossa; (5) the silicone cable leading subperiostally to the retro-auricular space (green).
performed frequently for study purposes, must be condsidered. CT is the only means to visualise the implant's parts outside the eye in high resolution, which in our case can be estimated to be about 0.1 mm. CT images are readily transferrable to external software to construct a 3D image. In these images, meaningful measurements of dimensions of the implant could be performed.
CT pictures of such high resolution can show all the technical aspects of the implant and give valuable indications for research Figure 5 Three dimensional (3D) reconstructions of CT scans of patient 2 with a subretinal implant. The scans were taken 2 months after implantation; the implant was complete with the clamp in the retro-auricular space and its external parts. All parts of the implant are also clearly visible as in figure 1 and have been coloured identically; in addition, the metal clamp is coloured turquoise. Figure 6 Orbital details of CT scans in three-dimensional (3D) reconstructions under different directions of gaze. Of the nine directions of gaze scanned only those where implant movements are extreme are shown, that is, in direction or away from the direction of the orbital entry point. The implant's movements can be detected by comparing the position of the blue subretinal tip and the episcleral fixation pads of the polyimide foil (red). Quicktime animation (downloadable) images similar to those in figure 1 were used to compile a self-manoeuvrable animation, which also allows cranial, caudal and oblique views (see Supplementary video; Quicktime is needed to manoeuvre the images (http://www.apple.com/quicktime/)).
purposes and in case of technical problems. The images also deliver data on the tissue reaction (biocompatibility) and can visualise the behaviour of the implant under eye movements. Last but not least, such 3D images and animations are excellent for illustrations and instructional purposes.
Epiretinal as well as subretinal implants currently mostly utilise extra-ocular connections for energy and signal conduction. Since they are still implanted under clinical trial conditions, adequate monitoring tools are mandatory to study the integrity of the device (biostability) and the body's reaction to it (biocompatibility). We believe that high-resolution CTscans can contribute to the success of these implants by delivering adequate imaging material.
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